$9.88
0.090.92%
At close: Nov 13, 4:00 PM EST
$10.05
0.171.72%
After Hours: Nov 13, 7:55 PM EST
Biodesix Inc
BDSXNASDAQ
Biodesix (BDSX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $-0.75 | $-0.75 | 0.00 % |
| Q2 | Aug 5, 2026 | $-0.71 | $-0.89 | 20.2 % |
| Q1 | May 4, 2026 | $-0.81 | $-1.13 | 28.3 % |
| Q4 | Feb 26, 2026 | $-0.49 | $-0.94 | 47.9 % |
Quarterly Revenue (Billions)
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $24.04M | $27.44M | -12.4 % |
| Q2 | Aug 5, 2026 | $26.86M | $25.94M | 3.54 % |
| Q1 | May 4, 2026 | $25.56M | $23.09M | 10.7 % |
| Q4 | Feb 26, 2026 | $28.76M | $25.83M | 11.3 % |
Biodesix (BDSX) last issued guidance on November 5, 2026 for fiscal year 2026. The company guided revenue in the range of $101M - $103M for the period.
Compared to prior guidance, Biodesix lowered its revenue forecast from a prior range of $108M - $114M.
Biodesix has issued 20 guidance updates between March 6, 2023 and November 5, 2026. During this period, the company raised its outlook 7 times and lowered it 5 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.75 | $-0.89 | $-1.13 | $-0.94 |
| Actual | $-0.75 | $-0.71 | $-0.81 | $-0.49 |
| Surprise | 0.00% | +20.2% | +28.3% | +47.9% |
| Revenue | ||||
| Estimate | $27.4M | $25.9M | $23.1M | $25.8M |
| Actual | $24.0M | $26.9M | $25.6M | $28.8M |
| Surprise | -12.4% | +3.54% | +10.7% | +11.3% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.63 | $-0.67 | $-0.50 | $-0.46 |
| Revenue | ||||
| Consensus | $27.1M | $28.5M | — | — |
